Infants Born to Mothers with Clinical Chorioamnionitis: A Cross-Sectional Survey on the Use of Early-Onset Sepsis Risk Calculator and Prolonged Use of Antibiotics

Abstract

Objective To evaluate variations in practice for the management of neonates born to mothers with clinical chorioamnionitis.

Methods This was a prospective cross-sectional survey consisting of 10 multiple choice questionnaires distributed to 2,900 members of the Perinatal Section of American Academy of Pediatrics. Variations in responses were assessed and compared between the various groups.

Results A total of 682 members (23.5%) completed the survey; 169 (24.8%) indicated that they use the neonatal early-onset sepsis (EOS) risk calculator for the management of neonates born to mothers with clinical chorioamnionitis. More respondents from the western region of United States and level III units are using the EOS risk calculator compared with the south and level II units. Approximately 44% of the respondents indicated that they will not stop antibiotics at 48 to 72 hours in asymptomatic neonates born to mothers with chorioamnionitis with negative blood culture if the complete blood count (CBC) and C-reactive protein (CRP) are abnormal.

Conclusion A large number of practitioners are using the neonatal EOS risk calculator for neonates born to mothers with chorioamnionitis. Despite a clear guideline from the Committee on Fetus and Newborn, almost 44% will treat healthy-appearing neonates born to mothers with chorioamnionitis with a prolonged course of antibiotics solely for abnormal CBC or CRP.

Keywords

sepsis - neonates - EOS calculator - maternal fever

• References

• 1 Verani JR, McGee L, Schrag SJ. ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. MMWR Recomm Rep 2010; 59 (RR-10): 1-36
• 2 Polin RA. ; Committee on Fetus and Newborn. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics 2012; 129 (05) 1006-1015
• 3 Kiser C, Nawab U, McKenna K, Aghai ZH. Role of guidelines on length of therapy in chorioamnionitis and neonatal sepsis. Pediatrics 2014; 133 (06) 992-998
• 4 Escobar GJ, Puopolo KM, Wi S. , et al. Stratification of risk of early-onset sepsis in newborns ≥ 34 weeks' gestation. Pediatrics 2014; 133 (01) 30-36
• 5 Gibbs RS, Dinsmoor MJ, Newton ER, Ramamurthy RS. A randomized trial of intrapartum versus immediate postpartum treatment of women with intra-amniotic infection. Obstet Gynecol 1988; 72 (06) 823-828
• 6 Sperling RS, Ramamurthy RS, Gibbs RS. A comparison of intrapartum versus immediate postpartum treatment of intra-amniotic infection. Obstet Gynecol 1987; 70 (06) 861-865
• 7 Hsu KK, Pelton SI, Shapiro DS. Detection of group B streptococcal bacteremia in simulated intrapartum antimicrobial prophylaxis. Diagn Microbiol Infect Dis 2003; 45 (01) 23-27
• 8 Shakib J, Buchi K, Smith E, Young PC. Management of newborns born to mothers with chorioamnionitis: is it time for a kinder, gentler approach?. Acad Pediatr 2015; 15 (03) 340-344
• 9 Polin RA, Watterberg K, Benitz W, Eichenwald E. The conundrum of early-onset sepsis. Pediatrics 2014; 133 (06) 1122-1123
• 10 Carola D, Vasconcellos M, Sloane A. , et al. Utility of early-onset sepsis risk calculator for neonates born to mothers with chorioamnionitis. J Pediatr 2018; 195: 48-52
• 11 Money N, Newman J, Demissie S, Roth P, Blau J. Anti-microbial stewardship: antibiotic use in well-appearing term neonates born to mothers with chorioamnionitis. J Perinatol 2017; 37 (12) 1304-1309
• 12 Alm B, Erdes L, Möllborg P. , et al. Neonatal antibiotic treatment is a risk factor for early wheezing. Pediatrics 2008; 121 (04) 697-702
• 13 Hviid A, Svanström H, Frisch M. Antibiotic use and inflammatory bowel diseases in childhood. Gut 2011; 60 (01) 49-54
• 14 Bailey LC, Forrest CB, Zhang P, Richards TM, Livshits A, DeRusso PA. Association of antibiotics in infancy with early childhood obesity. JAMA Pediatr 2014; 168 (11) 1063-1069
• 15 Kuzniewicz MW, Puopolo KM, Fischer A. , et al. A quantitative, risk-based approach to the management of neonatal early-onset sepsis. JAMA Pediatr 2017; 171 (04) 365-371
• 16 Rajbhandari S, La Gamma EF. Early-onset sepsis calculator-risk of delaying treatment. JAMA Pediatr 2017; 171 (10) 1015
• 17 Kerste M, Corver J, Sonnevelt MC. , et al. Application of sepsis calculator in newborns with suspected infection. J Matern Fetal Neonatal Med 2016; 29 (23) 3860-3865
• 18 Mukhopadhyay S, Taylor JA, Von Kohorn I. , et al. Variation in sepsis evaluation across a national network of nurseries. Pediatrics 2017; 139 (03) e20162845
• 19 Escobar GJ, Li DK, Armstrong MA. , et al. Neonatal sepsis workups in infants >/=2000 grams at birth: a population-based study. Pediatrics 2000; 106 (2 Pt 1): 256-263
• 20 Gerdes JS, Polin RA. Sepsis screen in neonates with evaluation of plasma fibronectin. Pediatr Infect Dis J 1987; 6 (05) 443-446
• 21 Benitz WE, Han MY, Madan A, Ramachandra P. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics 1998; 102 (04) E41
• 22 Benitz WE, Wynn JL, Polin RA. Reappraisal of guidelines for management of neonates with suspected early-onset sepsis. J Pediatr 2015; 166 (04) 1070-1074
• 23 Bhandari V. Effective biomarkers for diagnosis of neonatal sepsis. J Pediatric Infect Dis Soc 2014; 3 (03) 234-245
• 24 Cantey JB, Baird SD. Ending the culture of culture-negative sepsis in the neonatal ICU. Pediatrics 2017; 140 (04) e20170044